Soligenix, Inc. (SNGX)
0.3681
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
0.3681
0.00 (0.00%)
After-Hours: 20:00
Soligenix Shareholders Equity (Quarterly) : 6.646M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.646M |
| March 31, 2026 | 3.090M |
| December 31, 2025 | 5.292M |
| September 30, 2025 | 7.598M |
| June 30, 2025 | 1.829M |
| March 31, 2025 | 3.612M |
| December 31, 2024 | 4.118M |
| September 30, 2024 | 5.935M |
| June 30, 2024 | 3.465M |
| March 31, 2024 | 0.7684M |
| December 31, 2023 | 2.522M |
| September 30, 2023 | 4.221M |
| June 30, 2023 | 5.800M |
| March 31, 2023 | -3.387M |
| December 31, 2022 | -2.471M |
| September 30, 2022 | 1.032M |
| June 30, 2022 | 4.206M |
| March 31, 2022 | 6.584M |
| December 31, 2021 | 10.72M |
| September 30, 2021 | 15.05M |
| June 30, 2021 | 15.60M |
| March 31, 2021 | 17.32M |
| December 31, 2020 | 3.742M |
| September 30, 2020 | 7.406M |
| June 30, 2020 | 6.031M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.515M |
| December 31, 2019 | 1.457M |
| September 30, 2019 | 2.678M |
| June 30, 2019 | 3.636M |
| March 31, 2019 | 5.282M |
| December 31, 2018 | 6.280M |
| September 30, 2018 | 9.268M |
| June 30, 2018 | 2.623M |
| March 31, 2018 | 4.070M |
| December 31, 2017 | 6.320M |
| September 30, 2017 | 3.145M |
| June 30, 2017 | 3.622M |
| March 31, 2017 | 5.816M |
| December 31, 2016 | 7.397M |
| September 30, 2016 | 2.170M |
| June 30, 2016 | 0.0339M |
| March 31, 2016 | -1.050M |
| December 31, 2015 | -0.0183M |
| September 30, 2015 | -0.4662M |
| June 30, 2015 | -3.520M |
| March 31, 2015 | -1.826M |
| December 31, 2014 | -0.1539M |
| September 30, 2014 | -4.276M |
| June 30, 2014 | -4.664M |
| March 31, 2014 | -4.106M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.50M |
| Total Liabilities (Quarterly) | 3.854M |
| Debt to Equity Ratio | 0.0455 |
| Current Ratio | 2.769 |
| Net Debt Paydown Yield | -0.52% |